baccarateye| Yaoshi Technology (300725.SZ): Revenue from foreign customers accounted for 68.48% in 2023

Gelonghui May 9 丨 Pharmaceutical Stone Technology (300725)(300725baccarateye.SZ) said on the investor interaction platformbaccarateye, our company's products and services are mainly used in new drug research and development projects of pharmaceutical companies. Judging from the global innovative drug research and development pattern, overseas companies dominate, so the company's revenue mainly comes from overseas. In 2023, revenue from foreign customers accounted for 68.48%.